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Transmembrane protein coding genes are commonly associated with human diseases. We
characterized disease causing mutations and natural polymorphisms in transmembrane
proteins by mapping missense genetic variations from the UniProt database on the trans-
membrane protein topology listed in the Human Transmembrane Proteome database. We
found characteristic differences in the spectrum of amino acid changes within transmem-
brane regions: in the case of disease associated mutations the non-polar to non-polar and
non-polar to charged amino acid changes are equally frequent. In contrast, in the case of
natural polymorphisms non-polar to charged amino acid changes are rare while non-polar
to non-polar changes are common. The majority of disease associated mutations result in
glycine to arginine and leucine to proline substitutions. Mutations to positively charged
amino acids are more common in the center of the lipid bilayer, where they cause more
severe structural and functional anomalies. Our analysis contributes to the better under-
standing of the effect of disease associated mutations in transmembrane proteins, which
can help prioritize genetic variations in personal genomic investigations.
Introduction
Completion of the Human Genome Project resulted in a significant progression in genetic
research. The publication of the human reference sequence ignited several remarkable projects,
such as the 1000 Genomes Project [1], which provided a comprehensive resource of human
genetic variation; the Cancer Genome Atlas [2], which was launched to identify genetic muta-
tions in distinct tumor types; or the ENCODE project [3], which was established to identify
functional genomic elements. Despite the spate of data emerging from these projects, the rele-
vance of individual variations is not fully understood [4]. Transmembrane proteins (TMPs)
perform essential roles in cellular functions. Consequently, the smallest alteration in the
sequence of these proteins can have severe or fatal [5–8] effect. Furthermore, these proteins
participate in the communication between the cell and the environment, hence they can be
potential targets of drugs. Analysis of genetic variations in the context of the 3D structure of
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TMPs may help efforts to distinguish disease causing mutations and natural polymorphisms. A
notable example of this type of investigation was the mapping of disease associated mutations
to the homology model of human ABCC6, which is responsible for pseudoxanthoma elasticum
(PXE). In this study, significant clustering of the missense mutations was found at complex
domain-domain interfaces: at the transmission interface that involves four intracellular loops
and the two ABC domains as well as at the ABC-ABC interacting surfaces [9]. However, 3D
structure determination of TMPs lags behind the structure determination of globular proteins
since the crystallization of these proteins requires special techniques, and their size frequently
limits investigations by NMR spectroscopy. Fortunately, low-level structural information such
as the transmembrane topology of the proteins can be determined by various experimental
techniques [10,11] and can be also predicted with high accuracy [12–15]. A previous study of
80 TMPs has shown that disease-causing glycine to arginine changes are statistically frequent
in transmembrane (TM) regions [16]. There is strong evidence that these highly charged muta-
tions can cause misfolding of TMPs, which is one of the reasons behind the dysfunction of
these proteins [17]. In the case of FGFR3, the extra charge in the TM region provided by the
arginine leads to a disease [18]. However, it was also shown that arginine can play a naturally
essential role in the function of several TMPs, for example the voltage-gated potassium channel
KvAP contains arginines in the S4 hydrophobic segment [18].
The Human Transmembrane Proteome (HTP) database is one of the most complete
resources containing topology as well as 3D structural information of human TMPs [19]. This
comprehensive database provides a unique opportunity to examine the distribution of mis-
sense genetic variations and the spectrum of amino acid substitutions across the topological
segments of the human transmembrane proteome. In this work we analyzed the HTP to char-
acterize disease causing mutations and polymorphisms in the context of transmembrane topol-
ogy and KEGG enrichment.
Results
Genetic variations within transmembrane proteins
Genetic variations listed in the UniProt database [20] were mapped to the human transmem-
brane proteome. Altogether, 19513 genetic variations were identified, including 10952 poly-
morphisms and 8561 disease associated variants in 3153 and 642 TMPs, respectively (S1 File).
This result shows that there are about five times more TMPs carrying polymorphisms than
TMPs containing disease associated mutation(s). In the case of non-TMPs, we identified 26829
polymorphism and 15990 disease associated mutations within 8472 and 1552 proteins, respec-
tively. The rate of polymorphisms is 8,76x10-3 and 4,56x10-3 per residue in the TMPs and non-
TMPs, respectively. The rate of disease associated mutations is 2,57x10-2 and 1,36x10-2 per resi-
due in the TMPs and non-TMPs, respectively. These data show the relative enrichment of dis-
ease associated mutations in TMPs, which may be explained by the reduced tolerance of TMPs
to mutations.
TMPs with genetic variations have biased distribution across categories
of different TM region counts
The distribution of the number of TM regions in TMPs containing polymorphisms is in good
correlation with the distribution of TM regions in the whole HTP set (Fig 1). For example, the
percentage of 7 TM TMPs with polymorphisms is similar to that of 7 TM TMPs in the HTP set
(Fig 1). TMPs containing polymorphisms include 597 UniProt accesion IDs of TMPs contain-
ing 7 TM regions, which are unambiguously mapped to 591 unique Entrez Gene IDs using
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WebGestalt. About 50% of these (298) are classified as olfactory receptors by the KEGG enrich-
ment analysis. In view of the significant variability of olfactory receptors within the human
population [21,22], the high polymorphism rate in these TMPs is not surprising. As mentioned
above, disease associated mutations accumulate in fewer proteins than polymorphisms, and
the distribution of the number of TM segments in these two sets also shows significant differ-
ences. The relative decrease of the 7TM protein category within the disease associated mutation
containing TMPs is the most noticeable difference, while there is a minor increase in other TM
categories (with the exception of 1TM proteins, Fig 1). TMPs containing 10 or 12 TM regions
are especially relevant since these classes mostly contain ion transport proteins with essential
functions in the cell (as opposed to 7TMH TMPs determining the sense of smell). This analysis
clearly shows the different occurrences of the polymorphisms and disease associated mutations
in different types of TMPs.
Comparing the distribution of amino acid substitutions between
polymorphisms and disease associated mutations within distinct
topology segments of transmembrane proteins
Experimental determination of TMP structures has proved rather challenging [23–25]. There-
fore, bioinformatics tools play an important role in the prediction and investigation of structural
information. The topology of TMPs may be considered as a “low resolution structure”, which
determines the position of amino acid residues relative to the membrane plane. TMPs contain
intracellular, transmembrane and extracytosolic segments (a more detailed description can be
found on the http://topdb.enzim.hu web page [26]). We examined the distribution of the fre-
quency of polymorphisms and disease associated mutations within these distinct segments by
normalizing the occurrences of variations to the length of the respective topological segments.
Fig 1. Distribution of genetic variations across transmembrane proteins. Blue bars represent proteins
from the Human Transmembrane Proteome database, red bars represent TMPs containing disease-
associated mutation(s), green bars represent TMPs containing polymorphism(s). TMPs with more than 12
TM segments were not included in the figure because of the low number of those proteins.
doi:10.1371/journal.pone.0151760.g001
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Interestingly, the highest frequency of polymorphisms and disease associated mutations are
found in the transmembrane regions (Fig 2). In the case of polymorphisms non-polar to non-
polar mutations are the most frequent (Table 1), whereas disease associated variations are typi-
cally non-polar to charged, and non-polar to non-polar mutations (Table 2). It is well known
that the α-helical structures of the TMPs consist of mostly non-polar amino acid residues, which
play a fundamental role in the formation of the hydrophobic TM segments and their interaction
with the lipid bilayer. Since these types of interactions are not specific, polymorphisms are fre-
quently tolerated as long as the resulting amino acid remains non-polar. In the case of disease
associated variations, non-polar to charged amino acid changes provide polarity to the TM
Fig 2. Substitution frequency within distinct regions of the TMP(s). Blue bars represent disease-
associated mutations, red bars represent polymorphisms. Values were counted within the distinct regions of
the proteins, and normalized to the length of each segment.
doi:10.1371/journal.pone.0151760.g002
Table 1. Relative frequency of the various type of amino acid substitutions within the TM regions
associated with polymorphisms.
% charged non-polar Polar
Charged 1,67±0,1 2,06±0,09 1,29±0,07
non-polar 4,22±0,13 53,83±0,41 18,35±0,35
Polar 2,65±0,1 13,09±0,23 2,84±0,11
doi:10.1371/journal.pone.0151760.t001
Table 2. Relative frequency of the various type of amino acid substitutions within the TM regions
associated with diseases.
% Charged non-polar polar
charged 3,68±0,2 3,86±0,15 3,94±0,12
non-polar 22,61±0,42 33,09±0,24 12,1±0,3
Polar 5,85±0,18 11,35±0,22 3,5±0,11
doi:10.1371/journal.pone.0151760.t002
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region, which disrupt the folding of the protein [16–18]. The most common polymorphisms in
the TM regions result in valine to leucine, isoleucine to valine, alanine to threonine and phenylal-
anine to leucine substitutions (Table 3). In contrast to these polymorphic variations, in the case
of disease associated mutations, the two most abundant changes are the glycine to arginine and
the leucine to proline mutations (Table 4). These substitutions can be easily explained in view of
the standard genetic code table, which shows that a single nucleotide change is sufficient to
change at least four codons to induce either glycine to arginine or leucine to proline change.
We counted the amino acid substitutions for each topological region (polymorphisms and
disease associated mutations) and compared the distributions to random sampling (S2 and S3
Files). Variations caused by the mutation of arginine residues are overrepresented in all topo-
logical segments, except within the transmembrane region where these amino acids are uncom-
mon. This high mutability is due to the naturally occurring deamination of CpG dinucleotides
in coding sequences. Polymorphisms within the TM regions are mainly apolar-to-apolar
changes as shown in Table 1. These changes are highly overrepresented (S2 File) and symmet-
rical (e.g. valine to isoleucine and isoleucine to valine changes). In the case of disease associated
mutations two prominent signatures can be identified (S3 File). First, cysteine residues are
highly mutated in the extra-cytosolic region of TMPs, which can destabilize protein structure
by altering disulphide bonds. The other change results in a glycine to arginine substitution
within the TM region, which is characterized in more detail below.
Characterizing the glycine to arginine and leucine to proline mutations
To assess the relevance of glycine to arginine mutations, their occurrence in the transmem-
brane segments was compared with that of the naturally occurring arginines and
Table 3. Relative frequency of amino acid substitutions. Mutated amino acids are shown in rows; mutant amino acids are shown in columns associated
with polymorphisms.
Polymorphisms
% A R N D C Q E G H I L K M F P S T W W V
A 0 0 0 0,12 0 0 0,31 0,43 0 0 0 0 0 0 0,74 1,05 5,54 0 0 4,06
R 0 0 0 0 0,49 0,55 0 0,25 0,37 0 0,18 0,06 0,12 0 0,18 0,06 0 0,31 0 0
N 0 0 0 0,25 0 0 0 0 0,06 0,25 0 0,31 0 0 0 0,62 0,06 0 0 0
D 0,06 0 0,25 0 0 0 0,12 0,12 0,12 0 0 0 0 0 0 0 0 0 0,06 0
C 0 0,55 0 0 0 0 0 0,31 0 0 0 0 0 0,12 0 0,43 0 0,43 0,55 0
Q 0 0,37 0 0 0 0 0 0 0,18 0 0 0 0 0 0 0 0 0 0 0
E 0,12 0 0 0,06 0 0,06 0 0 0 0 0 0,06 0 0 0 0 0 0 0 0,06
G 0,55 0,74 0 0,43 0,43 0 0,37 0 0 0 0 0 0 0 0 1,29 0 0,12 0 0,43
H 0 0,62 0,12 0 0 0,06 0 0 0 0 0 0 0 0 0 0 0 0 0 0
I 0 0 0,43 0 0 0 0 0 0 0 0,68 0 0,92 0,55 0 0,12 3,69 0 0 6,09
L 0 0,37 0 0 0 0,31 0 0 0,25 1,05 0 0 0,8 3,26 1,6 0,55 0 0,12 0 2,34
K 0 0,25 0,12 0 0 0 0 0 0 0 0 0 0,12 0 0 0 0 0 0 0
M 0 0,06 0 0 0 0 0 0 0 1,05 0,86 0,18 0 0 0 0 1,78 0 0 2,71
F 0 0 0 0 0,55 0 0 0 0 0,06 4,49 0 0 0 0 1,23 0 0 0,31 0,62
P 0,06 0,18 0 0 0 0,06 0 0 0,06 0 0,8 0 0 0 0 0,86 0,12 0 0 0
S 0,74 0,18 0,55 0 0,55 0 0 0,98 0 0,25 1,11 0 0 0,62 0,8 0 0,62 0,06 0,12 0
T 2,71 0,25 0,18 0 0 0 0 0 0 1,48 0 0,31 1,66 0 0,43 0,55 0 0 0 0
W 0 0,18 0 0 0,37 0 0 0,06 0 0 0,12 0 0 0 0 0,12 0 0 0 0
Y 0 0 0,06 0 1,35 0 0 0 0,74 0 0 0 0 0,18 0 0,18 0 0 0 0
V 1,78 0 0 0,18 0 0 0,25 0,8 0 7,01 2,28 0 4,37 0,55 0 0 0 0 0 0
doi:10.1371/journal.pone.0151760.t003
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polymorphisms resulting in arginine within the transmembrane regions (Fig 3). The disease
associated glycine to arginine mutations were identified mostly in the center of the lipid bilayer,
contrary to the naturally occurring arginines and polymorphisms, which are common towards
the polar head groups of the lipid bilayer, in line with the notion that the extra charge in the
depth of the lipid bilayer leads to a more severe deviation in the structure and function of the
TMPs. Interestingly, naturally occurring arginine residues within TM segments can be found
almost exclusively within TMPs containing 7 TM regions. Glycine to arginine mutations are
frequently present in TMPs containing 10 and 12 TM regions (Fig 4). This observation suggests
that arginines naturally occurring in TMPs containing 7 TM regions (mostly G protein-cou-
pled receptors) have a dedicated role, in comparison to ion channels or ion transport proteins
where similar variations result in a disease phenotype.
The leucine to proline variations are non-polar to non-polar substitutions, hence these are
not providing extra charge into the TM region by the amino acid side chains. However, proline
can cause major disturbances by disrupting the hydrogen bridge system of the α-helices and
exposing a hydrogen bridge acceptor, which provides a partial extra charge within the lipid
bilayer. Therefore, it is not surprising that the enrichment analysis revealed that TMPs contain-
ing this type of mutations are frequent among the10 and 12 TM TMPs with ion transport func-
tion. A bootstrap method performed to estimate the significance of the observed count of
mutations revealed that glycine to arginine and leucine to proline mutations located in trans-
membrane segments significantly differ from each other. While the glycine to arginine muta-
tion was found to be highly significant, the high count of leucine to proline mutations is the
result of chance (see S2 and S3 Files).
Table 4. Relative frequency of amino acid substitutions. Mutated amino acids are shown in rows; mutant amino acids are shown in columns associated
with diseases.
Disease associated mutations
% A R N D C Q E G H I L K M F P S T W W V
A 0 0 0 1,39 0 0 0,98 0,46 0 0,05 0 0 0 0 1,19 0,26 2,53 0 0 2,68
R 0 0 0 0 1,08 1,14 0,05 0,15 1,39 0 0,36 0 0,05 0 0,36 0,26 0 0,83 0 0
N 0 0 0 0,62 0 0 0 0 0,1 0,36 0 0,72 0 0 0 0,77 0,15 0 0,21 0
D 0 0 0,88 0 0 0 0,15 0,26 0,15 0 0 0 0 0 0 0 0 0 0,67 0,21
C 0 1,65 0 0 0 0 0 0,15 0 0 0 0 0 0,15 0 0,21 0 0,26 0,98 0
Q 0 0,36 0 0 0 0 0,05 0 0,15 0 0,1 0,15 0 0 0,21 0 0 0 0 0
E 0 0 0 0,1 0 0,05 0 0,36 0 0 0 0,93 0 0 0 0 0 0 0 0
G 0,72 6,91 0 2,63 0,41 0 1,7 0 0 0 0,05 0,05 0 0 0 1,7 0 0,26 0 1,91
H 0 0,77 0,05 0,05 0 0,21 0 0 0 0 0,05 0 0 0 0,21 0 0 0 0,46 0
I 0 0,21 0,83 0 0 0 0 0 0 0 0,26 0,31 0,41 0,72 0 0,31 0,62 0 0 0,67
L 0 1,81 0 0 0 0,26 0 0 0,46 0,21 0 0 0,15 1,14 5,47 0,46 0 0,26 0 0,88
K 0 0 0,1 0 0 0 0,1 0 0 0 0 0 0 0 0 0 0,1 0 0 0
M 0 0,67 0 0 0 0 0 0 0 1,03 0,31 0,83 0 0 0 0 0,98 0 0 1,08
F 0 0 0 0 0,46 0 0 0 0 0,1 1,81 0 0 0 0 1,14 0,05 0 0,05 0,36
P 0,21 0,72 0 0 0 0,15 0 0 0,1 0 1,81 0 0 0 0 1,08 0,1 0 0 0
S 0 1,34 0,67 0 0,36 0 0 0,1 0 0,57 1,29 0 0 1,55 1,14 0 0,1 0,36 0,57 0
T 0,46 1,14 0,41 0 0 0 0 0 0 0,98 0 0,46 1,65 0 0,52 0,15 0 0 0 0
W 0 1,19 0 0 0,72 0 0 0,05 0 0 0,21 0 0 0 0 0,41 0 0 0 0
Y 0 0 0,1 0,15 1,6 0 0 0 0,62 0 0 0 0 0 0 0,36 0 0 0 0
V 0,72 0 0 0,62 0 0 0,41 0,31 0 1,7 0,57 0 2,06 1,03 0 0 0 0 0 0
doi:10.1371/journal.pone.0151760.t004
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Fig 3. Relative frequencies of mutations in the membrane regions of transmembrane proteins. The
distance was measured in the sequence from the most central amino acid in the transmembrane region and
was normalized by the length (in residue) of the TM regions. Blue bars represent naturally occurring arginine
residues within the TM region. Red bars represent the glycine to arginine disease-associated mutations
within the TM region. Green bars represent all polymorphisms found within the TM region.
doi:10.1371/journal.pone.0151760.g003
Fig 4. Distribution of TMPs containing naturally occurring arginine amino acids and disease
associated glycine to arginine mutations within the TM region. Blue bars represent those proteins which
contain arginine residue(s) in the TM segment. Red bars represent those proteins which contain disease-
associated glycine to arginine mutation(s) within the TM segment.
doi:10.1371/journal.pone.0151760.g004
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Additionally we determined a “predictive value” for those mutations which occur frequently
(more than hundred times) within the TM region (S4 File). This analysis clearly shows that the
glycine to arginine changes in the membrane regions are the highest occurring disease causing
mutations.
The relative frequencies of polymorphisms and disease associated mutations were further
characterized by mapping their positions on available 3D structures. The distribution of the
variations was evaluated along the z-axis (Fig 5). While the distribution of polymorphisms
show no significant changes along the z-axis, the distribution of the relative frequencies of dis-
ease associated mutations are more abundant in the middle of the double lipid layer, similarly
to the distribution of glycine to arginine variations. However, our analysis also revealed that
the disease associated mutations have two other maximums close to the head groups of the
lipid molecules in the cytosolic membrane leaflet (~38Å) and in the cytosolic water soluble
part of TMPs (~50Å) (Fig 5).
Discussion
In this study we combined information obtained from the Human Transmembrane Proteome
and UniProt databases to analyze the characteristics of naturally occurring missense genetic
mutations in human TMPs. In particular, our aim was to compare the distribution of polymor-
phic and disease associated variations within distinct protein segments of several TMP classes.
Despite the similar distribution of polymorphisms and disease associated mutations across
topological regions, the composition of the amino acid changes were found to be different. In
the case of polymorphic variations, changes within the TM regions most frequently retain the
apolar nature of the amino acids, whereas disease associated mutations result in characteristic
apolar to charged or apolar to apolar changes. The amino acid residue substitution matrix of
the human transmembrane proteome reveals that the glycine to arginine changes are primarily
Fig 5. Distribution of relative frequencies of mutations along the z-axis. The relative frequencies of
disease causing mutations (blue) and polymorphisms (red) are shown along the z-axis See Materials and
Methods for details.
doi:10.1371/journal.pone.0151760.g005
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responsible for this phenomenon (Table 4). This makes sense, since the arginine residue pro-
vides an extra charge in the lipid bilayer, which may dramatically alter the structure and func-
tion of TMPs. Although arginines occur rarely in the membrane spanning regions of TMP,
there are examples of naturally occurring arginine residues within the TM segments of TMPs.
We find that arginines introduced into the membrane spanning segment by the glycine to argi-
nine amino acid variations accumulate primarily within the interior of the lipid bilayer.
Glycine to arginine changes are more likely to be relevant when the variation affects a con-
served position. For example, the p.Gly833Argmutation causes a 78% reduction in the expres-
sion of the GRIA3 protein [27]. There are several literature reports that confirm the
pathological relevance of glycine to arginine changes within the membrane regions of TMPs.
For example, the p.Gly380Argmutation in the FGFR3 protein is believed to be responsible for
achondroplasia, [28]; the p.Gly185Arg change in the NRAMP2 protein results in microcytic
aneamia in humans [29]; the p.Gly796Arg variation in the Band3 protein causes hereditary sto-
matocytosis [30]. Interestingly, this latter mutation is not listed in the major mutational data-
bases including UniProt, Ensembl, or dbSNP. Since the UniProt classification of missense
mutations represents the probability of disease association (based on theoretical consider-
ations; see the description at the website: http://www.uniprot.org/docs/humsavar), it cannot be
used for clinical or diagnostic use. Surprisingly, our analysis identified 12 glycine to arginine
variations in the membrane spanning segments of TMPs that are nevertheless annotated as
polymorphisms in the UniProt database (see S6 File). Analysis of the literature revealed that
three of these variations result in altered phenotypes (two being disease causing, the
rs34059508 and rs36209700 variants in the SLC22A1 [31] and ABCG8 [32] proteins respec-
tively), suggesting that these variations are misclassified in the UniProt. The six remaining vari-
ations occur rarely in the human population, which may explain why a phenotype has not
been identified. In fact, the erroneous annotation of sequence variations may have clinically rel-
evant consequences. For example, a study found that 87% of patients with fibrodysplasia ossifi-
cans progressiva (FOP) were originally misdiagnosed [33], and the link of an atypical variation
to the disease was only revealed by whole exome sequencing [34].
The identification of relevant mutations in whole genomes has been linked to finding a nee-
dle in a haystack [35]. Today, ongoing efforts in the United States [36], Canada (the FORGE
project [37,38]) and in the UK (The Rare Diseases Genomes Project of Genomics England) are
sequencing thousands of genomes to identify genes that responsible for rare Mendelian dis-
eases. In this era of genomic data deluge, when sequencing machines generate more data than
researchers can analyze, the evaluation of the relevance of sequence variations is increasingly
important. We suggest that low resolution structural information, such as the transmembrane
topology of TMPs provides an important contribution to the evaluation of the functional rele-
vance of genetic variations. The analysis of sequence variations in the context of topological
information should help the identification of functionally relevant mutations that are more
likely to be associated with a clinically relevant phenotype.
Materials and Methods
Databases
Human genetic variation data (polymorphisms and disease mutations) was obtained from the
UniProt database (version 2014_10) (http://www.uniprot.org/docs/humsavar.txt, date of
release: 29-Oct-2014) [39]. This release contains 69978 naturally occurring human genetic mis-
sense variations, among these 25310 are disease associated, 38030 are polymorphisms, and
6638 are unclassified respectively.
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Identifiers of human non-TMPs as well as the topology information for the human TMPs
were imported from the HTP database (http://htp.enzim.hu/data/database/sets/htp_all_
uniprot13_03.xml) [19]. The downloaded version of HTP database consists of 14586 non-TM
and 4998 TMPs.
Analyzing the human transmembrane protein variations
Genetic variations for the 4998 human α-helical TMPs as well as for the 14586 non-TMPs
were imported from the UniProt database. The unclassified mutations were excluded from the
analysis. All topology and variation data for TMPs were converted to the standard Bed format
[40], using the UniProt ID and the position of the variant and were inserted before the original
columns of the annotation. Ambiguous variations associated with multiple diseases were
removed. In the case of multi-pass membrane proteins, we distinguished the terminals (regions
before the first and after the last TM segments) from the loop regions and added this informa-
tion to the converted files (e.g., N-terminal, Loop, C-terminal). The overlaps between the varia-
tions and the different segments of topology were determined by the intersectBed program,
with the option—wo, from the Bedtools software package version v2.17.0 [41]. A step by step
description of these preanalytical steps can be found in the S5 File. Using the original UniProt
annotation of these variations within the different topological sites, the exact amino acid substi-
tutions and the grouping by the polar/non-polar/charged protein property were counted by a
Perl script. We counted asparagine, glutamine, serine, threonine and tyrosine as polar residues;
alanine, cysteine, glycine, isoleucine, leucine, metionine, phenylalanin, proline, tryptophan and
valine as non-polar residues; arginine, aspartic acid, glutamic acid, histidine, and lysine as
charged residues. To estimate the standard deviation of the distribution of the various substitu-
tion types, we applied a bootstrap method by selecting the 90% of variations from the disease
associated and polymorphism groups by chance for ten times, and the mean and standard devi-
ation values from the ten cases were calculated. The significance of the observed amino acid
substitution matrix for the different topological sites was tested. In the case of the three topo-
logical sites (inside, membrane, outside) positions were randomly chosen for every observed
mutant sites from amino acid sequences located within those regions. The observed substitu-
tion rate was used to construct a random substitution matrix for the amino acid changes. This
method was applied a hundred times and the average and standard deviation values were deter-
mined to all substitutions, then the significance of the observed values was examined. The dis-
tance of the glycine to arginine variations from the center of the transmembrane region was
computed by a Perl script. The enrichment analyses were determined by the WebGestalt web
service [42], using the default options, and the hsapiens__entrezgene_protein-coding reference
set. The EMBOSS software package version 6.3.1 was used to manipulate the raw protein
sequences, and to obtain the information of protein sequences [43]. The perl scripts can be
downloaded from the following web page: http://mbk.enzim.ttk.mta.hu/TMmutations.
For the investigation of the distribution of mutations in the 3D structures of TMPs, the
polymorphisms and disease associated mutations were mapped onto the 3D structures of
TMPs; the membrane normal was parallel with the z-axis and the zero point was in the middle
of the double lipid layer. The information for the necessary rotation was taken from the
PDBTM database [44]. The proteins were cut into 1Å wide slices parallel to the membrane
plane, and the number of polymorphisms and disease associated mutations as well as the num-
ber of all residues were summed for each TMP having homologous structure in PDBTM data-
base. The relative frequencies of mutations were calculated by dividing the sums by the sum of
all residues in each slice.
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Supporting Information
S1 File. Topological annotation of polymorphisms and disease associated mutations.
Human protein variation data was downloaded from the UniProt database release 29-Oct-
2014. The topology information was obtained from the HTP database version 1.0. The creation
of this file is described in the Materials and Methods section of this paper. The abbreviations
for the Topology_type are I (inside), M (membrane), O (outside).
(XLSX)
S2 File. The significance of the different amino acid substitutions of polymorphisms within
distinct topological sites. Tables represent the observed (OBS) values, the average values of ran-
dom sampling of hundred times (AVG), the standard deviation of the random sampling (STD)
and the ratio of the observed minus average and standard deviation values ((OBS-AVG)/STD).
(XLSX)
S3 File. The significance of the different amino acid substitutions of disease associated
mutations within distinct topological sites. Tables represent the observed (OBS) values, the
average values of random sampling of hundred times (AVG), the standard deviation of the ran-
dom sampling (STD) and the ratio of the observed minus average and standard deviation val-
ues ((OBS-AVG)/STD).
(XLSX)
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